{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T13:01:14Z","timestamp":1780664474092,"version":"3.54.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2018A030313907"],"award-info":[{"award-number":["2018A030313907"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009330","name":"Medical Science and Technology Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["A2023243"],"award-info":[{"award-number":["A2023243"]}],"id":[{"id":"10.13039\/501100009330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-05976-9","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T11:39:48Z","timestamp":1780659588000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["HM568 Enhances NAD+ Biosynthesis to Ameliorate Mitochondrial Dysfunction and Neurotoxicity in Parkinson's Disease Models: A Putative Link to PARP1 Modulation"],"prefix":"10.1007","volume":"63","author":[{"given":"Minpeng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingyuan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiye","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changmei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"issue":"7","key":"5976_CR1","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.amjmed.2019.03.001","volume":"132","author":"MT Hayes","year":"2019","unstructured":"Hayes MT (2019) Parkinson\u2019s Disease and parkinsonism. Am J Med 132(7):802\u2013807","journal-title":"Am J Med"},{"issue":"11","key":"5976_CR2","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41582-023-00874-3","volume":"19","author":"T Li","year":"2023","unstructured":"Li T, Le W, Jankovic J (2023) Linking the cerebellum to Parkinson disease: an update. Nat Rev Neurol 19(11):645\u2013654","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"5976_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrneurol.2014.226","volume":"11","author":"D Athauda","year":"2015","unstructured":"Athauda D, Foltynie T (2015) The ongoing pursuit of neuroprotective therapies in Parkinson disease. Nat Rev Neurol 11(1):25\u201340","journal-title":"Nat Rev Neurol"},{"issue":"8","key":"5976_CR4","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/j.1753-4887.2009.00221.x","volume":"67","author":"D Orsucci","year":"2009","unstructured":"Orsucci D, Filosto M, Siciliano G, Mancuso M (2009) Electron transfer mediators and other metabolites and cofactors in the treatment of mitochondrial dysfunction. Nutr Rev 67(8):427\u2013438","journal-title":"Nutr Rev"},{"issue":"9","key":"5976_CR5","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/s41593-022-01140-3","volume":"25","author":"ML Choi","year":"2022","unstructured":"Choi ML, Chappard A, Singh BP, Maclachlan C, Rodrigues M, Fedotova EI, Berezhnov AV, De S et al (2022) Pathological structural conversion of \u03b1-synuclein at the mitochondria induces neuronal toxicity. Nat Neurosci 25(9):1134\u20131148","journal-title":"Nat Neurosci"},{"issue":"12","key":"5976_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2023.167992","volume":"435","author":"T Sohrabi","year":"2023","unstructured":"Sohrabi T, Mirzaei-Behbahani B, Zadali R, Pirhaghi M, Morozova-Roche LA, Meratan AA (2023) Common mechanisms underlying \u03b1-synuclein-induced mitochondrial dysfunction in Parkinson\u2019s disease. J Mol Biol 435(12):167992","journal-title":"J Mol Biol"},{"key":"5976_CR7","doi-asserted-by":"crossref","unstructured":"Kam TI, Mao X, Park H, Chou SC, Karuppagounder SS, Umanah GE, Yun SP, Brahmachari S, et al (2018) Poly(ADP-ribose) drives pathologic \u03b1-synuclein neurodegeneration in Parkinson's disease. Science 362(6414)","DOI":"10.1126\/science.aat8407"},{"issue":"15","key":"5976_CR8","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2118819119","volume":"119","author":"JT Hinkle","year":"2022","unstructured":"Hinkle JT, Patel J, Panicker N, Karuppagounder SS, Biswas D, Belingon B, Chen R, Brahmachari S et al (2022) STING mediates neurodegeneration and neuroinflammation in nigrostriatal \u03b1-synucleinopathy. Proc Natl Acad Sci U S A 119(15):e2118819119","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"5976_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nm.4269","volume":"23","author":"YC Wong","year":"2017","unstructured":"Wong YC, Krainc D (2017) \u03b1-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies. Nat Med 23(2):1\u201313","journal-title":"Nat Med"},{"key":"5976_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.102078","volume":"91","author":"ML Hu","year":"2023","unstructured":"Hu ML, Pan YR, Yong YY, Liu Y, Yu L, Qin DL, Qiao G, Law BY et al (2023) Poly (ADP-ribose) polymerase 1 and neurodegenerative diseases: Past, present, and future. Ageing Res Rev 91:102078","journal-title":"Ageing Res Rev"},{"issue":"3","key":"5976_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.72","volume":"7","author":"S Lehmann","year":"2016","unstructured":"Lehmann S, Costa AC, Celardo I, Loh SH, Martins LM (2016) Parp mutations protect against mitochondrial dysfunction and neurodegeneration in a PARKIN model of Parkinson\u2019s disease. Cell Death Dis 7(3):e2166","journal-title":"Cell Death Dis"},{"issue":"1","key":"5976_CR12","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1016\/S1470-2045(18)30786-1","volume":"20","author":"CJ LaFargue","year":"2019","unstructured":"LaFargue CJ, Dal Molin GZ, Sood AK, Coleman RL (2019) Exploring and comparing adverse events between PARP inhibitors. Lancet Oncol 20(1):e15\u2013e28","journal-title":"Lancet Oncol"},{"issue":"12","key":"5976_CR13","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1016\/j.molcel.2022.02.021","volume":"82","author":"D Huang","year":"2022","unstructured":"Huang D, Kraus WL (2022) The expanding universe of PARP1-mediated molecular and therapeutic mechanisms. Mol Cell 82(12):2315\u20132334","journal-title":"Mol Cell"},{"issue":"25","key":"5976_CR14","doi-asserted-by":"publisher","first-page":"17860","DOI":"10.1074\/jbc.274.25.17860","volume":"274","author":"JC Am\u00e9","year":"1999","unstructured":"Am\u00e9 JC, Rolli V, Schreiber V, Niedergang C, Apiou F, Decker P, Muller S, H\u00f6ger T et al (1999) PARP-2, a novel mammalian DNA damage-dependent poly(ADP-ribose) polymerase. J Biol Chem 274(25):17860\u201317868","journal-title":"J Biol Chem"},{"issue":"7","key":"5976_CR15","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1038\/cdd.2014.202","volume":"22","author":"J Farr\u00e9s","year":"2015","unstructured":"Farr\u00e9s J, Llacuna L, Martin-Caballero J, Mart\u00ednez C, Lozano JJ, Ampurdan\u00e9s C, L\u00f3pez-Contreras AJ, Florensa L et al (2015) PARP-2 sustains erythropoiesis in mice by limiting replicative stress in erythroid progenitors. Cell Death Differ 22(7):1144\u20131157","journal-title":"Cell Death Differ"},{"issue":"19","key":"5976_CR16","doi-asserted-by":"publisher","first-page":"14498","DOI":"10.1021\/acs.jmedchem.1c01012","volume":"64","author":"JW Johannes","year":"2021","unstructured":"Johannes JW, Balazs A, Barratt D, Bista M, Chuba MD, Cosulich S, Critchlow SE, Degorce SL et al (2021) Discovery of 5-{4-[(7-Ethyl-6-oxo-5,6-dihydro-1,5-naphthyridin-3-yl)methyl]piperazin-1-yl}-N-methylpyridine-2-carboxamide (AZD5305): a PARP1-DNA trapper with high selectivity for PARP1 over PARP2 and other PARPs. J Med Chem 64(19):14498\u201314512","journal-title":"J Med Chem"},{"key":"5976_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22101752","volume":"22","author":"H Cao","year":"2017","unstructured":"Cao H, Liao S, Zhong W, Xiao X, Zhu J, Li W, Wu X, Feng Y (2017) Synthesis, characterization, and biological evaluations of 1,3,5-Triazine derivatives of Metformin cyclization with Berberine and Magnolol in the presence of Sodium Methylate. Molecules 22:10","journal-title":"Molecules"},{"issue":"7","key":"5976_CR18","first-page":"508","volume":"33","author":"T You-zhen","year":"2023","unstructured":"You-zhen T, Xia W, Yi-fan F (2023) Design, synthesis, in vitro anti-inflammatory and anti-tumor activity evaluation of triazine derivatives of honokiol. Chin J Med Chem 33(7):508\u2013515","journal-title":"Chin J Med Chem"},{"key":"5976_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2024.111212","volume":"403","author":"C Zhong","year":"2024","unstructured":"Zhong C, Wang C, Li W, Li W, Chen X, Guo J, Feng Y, Wu X (2024) A derivative of honokiol HM568 has an anti-neuroinflammatory effect in Parkinson\u2019s disease. Chem Biol Interact 403:111212","journal-title":"Chem Biol Interact"},{"issue":"10","key":"5976_CR20","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1038\/s41401-025-01570-2","volume":"46","author":"JQ Zhang","year":"2025","unstructured":"Zhang JQ, Li SY, Yin C, Ji Y, Zhang X, Liu DY, Yang H, Niu Y et al (2025) Dysfunction of subthalamic dopaminergic circuitry contributes to anxiety- and depression-like behaviors in 6-OHDA lesion-induced hemiparkinsonian mice. Acta Pharmacol Sin 46(10):2622\u20132636","journal-title":"Acta Pharmacol Sin"},{"key":"5976_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12990-015-0026-1","volume":"11","author":"J Park","year":"2015","unstructured":"Park J, Lim CS, Seo H, Park CA, Zhuo M, Kaang BK, Lee K (2015) Pain perception in acute model mice of Parkinson\u2019s disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Mol Pain 11:28","journal-title":"Mol Pain"},{"issue":"7","key":"5976_CR22","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s10571-020-00804-7","volume":"40","author":"J Yan","year":"2020","unstructured":"Yan J, Liu A, Fan H, Qiao L, Wu J, Shen M, Lai X, Huang J (2020) Simvastatin improves behavioral disorders and hippocampal inflammatory reaction by NMDA-mediated anti-inflammatory function in MPTP-treated mice. Cell Mol Neurobiol 40(7):1155\u20131164","journal-title":"Cell Mol Neurobiol"},{"key":"5976_CR23","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.bbi.2022.09.002","volume":"106","author":"J Huang","year":"2022","unstructured":"Huang J, Ding J, Wang X, Gu C, He Y, Li Y, Fan H, Xie Q et al (2022) Transfer of neuron-derived \u03b1-synuclein to astrocytes induces neuroinflammation and blood-brain barrier damage after methamphetamine exposure: Involving the regulation of nuclear receptor-associated protein 1. Brain Behav Immun 106:247\u2013261","journal-title":"Brain Behav Immun"},{"issue":"1","key":"5976_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-025-04663-1","volume":"16","author":"T Wang","year":"2025","unstructured":"Wang T, Li Y, Tian J, Sun G, Yang T, Meng Z, Li W, Su X et al (2025) PARP inhibition augments immunomodulatory function of mesenchymal stem\/stromal cells by promoting STAT1 phosphorylation. Stem Cell Res Ther 16(1):548","journal-title":"Stem Cell Res Ther"},{"key":"5976_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2023.106618","volume":"138","author":"P Sundararajan","year":"2023","unstructured":"Sundararajan P, Dharmaraj Rajaselvi D, Vivekananthan S, Priya Ramasamy S (2023) In-silico method for elucidation of prodigiosin as PARP-1 inhibitor a prime target of triple-negative breast cancer. Bioorg Chem 138:106618","journal-title":"Bioorg Chem"},{"key":"5976_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.593026","volume":"11","author":"S Al-Bachari","year":"2020","unstructured":"Al-Bachari S, Naish JH, Parker GJM, Emsley HCA, Parkes LM (2020) Blood-brain barrier leakage is increased in Parkinson\u2019s Disease. Front Physiol 11:593026","journal-title":"Front Physiol"},{"key":"5976_CR27","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/s12276-022-00800-5","volume":"54","author":"B Qi","year":"2022","unstructured":"Qi B, Song L, Hu L, Guo D, Ren G, Peng T, Liu M, Fang Y et al (2022) Cardiac-specific overexpression of Ndufs1 ameliorates cardiac dysfunction after myocardial infarction by alleviating mitochondrial dysfunction and apoptosis. Exp Mol Med 54:946","journal-title":"Exp Mol Med"},{"key":"5976_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232213880","volume":"23","author":"S Guan","year":"2022","unstructured":"Guan S, Zhao L, Peng R (2022) Mitochondrial respiratory chain supercomplexes: From structure to function. Int J Mol Sci 23:22","journal-title":"Int J Mol Sci"},{"issue":"10-12","key":"5976_CR29","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1089\/ars.2023.0268","volume":"39","author":"I Kawano","year":"2023","unstructured":"Kawano I, Bazila B, Je\u017eek P, Dlaskov\u00e1 A (2023) Mitochondrial dynamics and cristae shape changes during metabolic reprogramming. Antioxid Redox Signal 39(10\u201312):684\u2013707","journal-title":"Antioxid Redox Signal"},{"key":"5976_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2025.103859","volume":"86","author":"N Ahmed Selim","year":"2025","unstructured":"Ahmed Selim N, Wojtovich AP (2025) Mitochondrial membrane potential and compartmentalized signaling: calcium, ROS, and beyond. Redox Biol 86:103859","journal-title":"Redox Biol"},{"issue":"7","key":"5976_CR31","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/sj.cdd.4402150","volume":"14","author":"DN Criddle","year":"2007","unstructured":"Criddle DN, Gerasimenko JV, Baumgartner HK, Jaffar M, Voronina S, Sutton R, Petersen OH, Gerasimenko OV (2007) Calcium signalling and pancreatic cell death: apoptosis or necrosis? Cell Death Differ 14(7):1285\u20131294","journal-title":"Cell Death Differ"},{"key":"5976_CR32","doi-asserted-by":"crossref","unstructured":"Schiuma G, Lara D, Clement J, Narducci M, Rizzo R (2024) Nicotinamide adenine dinucleotide: the redox sensor in aging-related disorders. Antioxid Redox Signal","DOI":"10.1089\/ars.2023.0375"},{"issue":"12","key":"5976_CR33","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1038\/s12276-022-00894-x","volume":"54","author":"JH Lee","year":"2022","unstructured":"Lee JH, Hussain M, Kim EW, Cheng SJ, Leung AKL, Fakouri NB, Croteau DL, Bohr VA (2022) Mitochondrial PARP1 regulates NAD(+)-dependent poly ADP-ribosylation of mitochondrial nucleoids. Exp Mol Med 54(12):2135\u20132147","journal-title":"Exp Mol Med"},{"key":"5976_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.01.014","volume":"38","author":"S Hurtado-Bag\u00e8s","year":"2020","unstructured":"Hurtado-Bag\u00e8s S, Knobloch G, Ladurner AG, Buschbeck M (2020) The taming of PARP1 and its impact on NAD(+) metabolism. Mol Metab 38:100950","journal-title":"Mol Metab"},{"key":"5976_CR35","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.mito.2022.02.003","volume":"64","author":"K Zambrano","year":"2022","unstructured":"Zambrano K, Barba D, Castillo K, Noboa L, Argueta-Zamora D, Robayo P, Arizaga E, Caicedo A et al (2022) Fighting Parkinson\u2019s disease: the return of the mitochondria. Mitochondrion 64:34\u201344","journal-title":"Mitochondrion"},{"issue":"9","key":"5976_CR36","doi-asserted-by":"publisher","first-page":"3646","DOI":"10.1007\/s12035-020-01947-w","volume":"57","author":"T Pa\u00df","year":"2020","unstructured":"Pa\u00df T, A\u00dffalg M, Tolve M, Blaess S, Rothermel M, Wiesner RJ, Ricke KM (2020) The impact of mitochondrial dysfunction on dopaminergic neurons in the olfactory bulb and odor detection. Mol Neurobiol 57(9):3646\u20133657","journal-title":"Mol Neurobiol"},{"key":"5976_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2022.104792","volume":"140","author":"A Narmashiri","year":"2022","unstructured":"Narmashiri A, Abbaszadeh M, Ghazizadeh A (2022) The effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on the cognitive and motor functions in rodents: A systematic review and meta-analysis. Neurosci Biobehav Rev 140:104792","journal-title":"Neurosci Biobehav Rev"},{"key":"5976_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2018.00398","volume":"12","author":"I Garc\u00eda-Dom\u00ednguez","year":"2018","unstructured":"Garc\u00eda-Dom\u00ednguez I, Vesel\u00e1 K, Garc\u00eda-Revilla J, Carrillo-Jim\u00e9nez A, Roca-Ceballos MA, Santiago M, de Pablos RM, Venero JL (2018) Peripheral inflammation enhances microglia response and nigral dopaminergic cell death in an in vivo MPTP model of Parkinson\u2019s Disease. Front Cell Neurosci 12:398","journal-title":"Front Cell Neurosci"},{"issue":"2","key":"5976_CR39","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41418-018-0124-5","volume":"26","author":"E Lee","year":"2019","unstructured":"Lee E, Hwang I, Park S, Hong S, Hwang B, Cho Y, Son J, Yu JW (2019) MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration. Cell Death Differ 26(2):213\u2013228","journal-title":"Cell Death Differ"},{"issue":"3","key":"5976_CR40","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00702-010-0489-1","volume":"118","author":"FJ G\u00f3mez","year":"2011","unstructured":"G\u00f3mez FJ, Aguirre P, Gonzalez-Billault C, N\u00fa\u00f1ez MT (2011) Iron mediates neuritic tree collapse in mesencephalic neurons treated with 1-methyl-4-phenylpyridinium (MPP+). J Neural Transm 118(3):421\u2013431","journal-title":"J Neural Transm"},{"issue":"15","key":"5976_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202203106","volume":"12","author":"P He","year":"2023","unstructured":"He P, Liu F, Li M, Ren M, Wang X, Deng Y, Wu X, Li Y et al (2023) Mitochondrial calcium ion nanogluttons alleviate periodontitis via controlling mPTPs. Adv Healthc Mater 12(15):e2203106","journal-title":"Adv Healthc Mater"},{"issue":"12","key":"5976_CR42","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1007\/s11010-024-04935-z","volume":"479","author":"TA Kavalenia","year":"2024","unstructured":"Kavalenia TA, Lapshina EA, Ilyich TV, Zhao HC, Zavodnik IB (2024) Functional activity and morphology of isolated rat cardiac mitochondria under calcium overload. Effect of naringin. Mol Cell Biochem 479(12):3329\u20133340","journal-title":"Mol Cell Biochem"},{"issue":"17","key":"5976_CR43","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1523\/JNEUROSCI.4000-04.2005","volume":"25","author":"R Kov\u00e1cs","year":"2005","unstructured":"Kov\u00e1cs R, Kardos J, Heinemann U, Kann O (2005) Mitochondrial calcium ion and membrane potential transients follow the pattern of epileptiform discharges in hippocampal slice cultures. J Neurosci 25(17):4260\u20134269","journal-title":"J Neurosci"},{"issue":"3","key":"5976_CR44","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.tem.2013.12.001","volume":"25","author":"HC Chang","year":"2014","unstructured":"Chang HC, Guarente L (2014) SIRT1 and other sirtuins in metabolism. Trends Endocrinol Metab 25(3):138\u2013145","journal-title":"Trends Endocrinol Metab"},{"key":"5976_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23074054","author":"HC Tsai","year":"2022","unstructured":"Tsai HC, Hsieh CH, Hsu CW, Hsu YH, Chien LF (2022) Cloning and organelle expression of bamboo mitochondrial complex I subunits Nad1, Nad2, Nad4, and Nad5 in the yeast Saccharomyces cerevisiae. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23074054","journal-title":"Int J Mol Sci"},{"issue":"2","key":"5976_CR46","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41580-020-00313-x","volume":"22","author":"AJ Covarrubias","year":"2021","unstructured":"Covarrubias AJ, Perrone R, Grozio A, Verdin E (2021) NAD(+) metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol 22(2):119\u2013141","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5976_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2020.154431","volume":"115","author":"M Ahn","year":"2021","unstructured":"Ahn M, Oh E, McCown EM, Wang X, Veluthakal R, Thurmond DC (2021) A requirement for PAK1 to support mitochondrial function and maintain cellular redox balance via electron transport chain proteins to prevent \u03b2-cell apoptosis. Metabolism 115:154431","journal-title":"Metabolism"},{"key":"5976_CR48","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.freeradbiomed.2025.03.029","volume":"233","author":"J Mercola","year":"2025","unstructured":"Mercola J (2025) Reductive stress and mitochondrial dysfunction: the hidden link in chronic disease. Free Radic Biol Med 233:118\u2013131","journal-title":"Free Radic Biol Med"},{"issue":"10","key":"5976_CR49","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1016\/j.celrep.2018.05.009","volume":"23","author":"DC Sch\u00f6ndorf","year":"2018","unstructured":"Sch\u00f6ndorf DC, Ivanyuk D, Baden P, Sanchez-Martinez A, De Cicco S, Yu C, Giunta I, Schwarz LK et al (2018) The NAD+ precursor nicotinamide riboside rescues mitochondrial defects and neuronal loss in iPSC and fly models of Parkinson\u2019s disease. Cell Rep 23(10):2976\u20132988","journal-title":"Cell Rep"},{"key":"5976_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2019.109670","volume":"94","author":"C Shan","year":"2019","unstructured":"Shan C, Gong YL, Zhuang QQ, Hou YF, Wang SM, Zhu Q, Huang GR, Tao B et al (2019) Protective effects of \u03b2- nicotinamide adenine dinucleotide against motor deficits and dopaminergic neuronal damage in a mouse model of Parkinson\u2019s disease. Prog Neuropsychopharmacol Biol Psychiatry 94:109670","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"5976_CR51","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.2741\/2909","volume":"13","author":"PO Hassa","year":"2008","unstructured":"Hassa PO, Hottiger MO (2008) The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases. Front Biosci Landmark Ed 13:3046\u20133082","journal-title":"Front Biosci Landmark Ed"},{"issue":"3","key":"5976_CR52","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s10059-013-0172-0","volume":"36","author":"SH Baek","year":"2013","unstructured":"Baek SH, Bae ON, Kim EK, Yu SW (2013) Induction of mitochondrial dysfunction by poly(ADP-ribose) polymer: implication for neuronal cell death. Mol Cells 36(3):258\u2013266","journal-title":"Mol Cells"},{"issue":"2","key":"5976_CR53","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1128\/MCB.01766-07","volume":"28","author":"M Niere","year":"2008","unstructured":"Niere M, Kernstock S, Koch-Nolte F, Ziegler M (2008) Functional localization of two poly(ADP-ribose)-degrading enzymes to the mitochondrial matrix. Mol Cell Biol 28(2):814\u2013824","journal-title":"Mol Cell Biol"},{"issue":"5","key":"5976_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007065","volume":"14","author":"JJ Wen","year":"2018","unstructured":"Wen JJ, Yin YW, Garg NJ (2018) PARP1 depletion improves mitochondrial and heart function in Chagas disease: effects on POLG dependent mtDNA maintenance. PLoS Pathog 14(5):e1007065","journal-title":"PLoS Pathog"},{"issue":"8","key":"5976_CR55","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.1073\/pnas.1013715108","volume":"108","author":"AG Patel","year":"2011","unstructured":"Patel AG, Sarkaria JN, Kaufmann SH (2011) Nonhomologous end joining drives poly(ADP-ribose) polymerase (PARP) inhibitor lethality in homologous recombination-deficient cells. Proc Natl Acad Sci U S A 108(8):3406\u20133411","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"5976_CR56","doi-asserted-by":"publisher","first-page":"3811","DOI":"10.1093\/nar\/gkz120","volume":"47","author":"EE Alemasova","year":"2019","unstructured":"Alemasova EE, Lavrik OI (2019) Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins. Nucleic Acids Res 47(8):3811\u20133827","journal-title":"Nucleic Acids Res"},{"issue":"21","key":"5976_CR57","doi-asserted-by":"publisher","first-page":"5588","DOI":"10.1158\/0008-5472.CAN-12-2753","volume":"72","author":"J Murai","year":"2012","unstructured":"Murai J, Huang SY, Das BB, Renaud A, Zhang Y, Doroshow JH, Ji J, Takeda S et al (2012) Trapping of PARP1 and PARP2 by clinical PARP inhibitors. Cancer Res 72(21):5588\u20135599","journal-title":"Cancer Res"},{"key":"5976_CR58","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.mad.2015.04.001","volume":"146-148","author":"S Martire","year":"2015","unstructured":"Martire S, Mosca L, d\u2019Erme M (2015) PARP-1 involvement in neurodegeneration: A focus on Alzheimer\u2019s and Parkinson\u2019s diseases. Mech Ageing Dev 146\u2013148:53\u201364","journal-title":"Mech Ageing Dev"},{"key":"5976_CR59","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.semcdb.2016.11.007","volume":"63","author":"P Narne","year":"2017","unstructured":"Narne P, Pandey V, Simhadri PK, Phanithi PB (2017) Poly(ADP-ribose)polymerase-1 hyperactivation in neurodegenerative diseases: the death knell tolls for neurons. Semin Cell Dev Biol 63:154\u2013166","journal-title":"Semin Cell Dev Biol"},{"issue":"11","key":"5976_CR60","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1038\/cdd.2016.99","volume":"23","author":"C Yu","year":"2016","unstructured":"Yu C, Kim BS, Kim E (2016) FAF1 mediates regulated necrosis through PARP1 activation upon oxidative stress leading to dopaminergic neurodegeneration. Cell Death Differ 23(11):1873\u20131885","journal-title":"Cell Death Differ"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05976-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-05976-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05976-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T12:02:57Z","timestamp":1780660977000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-05976-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5976"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-05976-9","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"23 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Number"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"677"}}